Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01725100
Title A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

Advanced Solid Tumor

Therapies

Trametinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Goodyear Arizona 85338 United States Details
GSK Investigational Site Scottsdale Arizona 85259 United States Details
GSK Investigational Site Sarasota Florida 34232 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field